Ken Griffin’s Maze Therapeutics MAZE Stock Holding History
Bought
Maintained
Sold
Other funds holding MAZE
Ken Griffin's MAZE Position: Q3 2026 in Review
Ken Griffin increased its Maze Therapeutics (MAZE) stake by 85% in Q3 2026, buying an estimated $20.2M and bringing the position to 1,579,818 shares worth $42.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1702.
Ken Griffin first reported a position in MAZE in Q1 2025 and has held it in 5 quarters since. 158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.
- Ken Griffin held 1,579,818 shares of Maze Therapeutics worth $42.9M as of Q3 2026.
- Ken Griffin bought 727,142 Maze Therapeutics shares in Q3 2026, an estimated $20.2M.
- Maze Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1702 holding.
- Ken Griffin first reported a position in Maze Therapeutics in Q1 2025 and has held it in 5 quarters since.
- 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.